Tosoh Corporation has announced it will increase the production capacity of separation and purification media.

Biosynth Carbosynth announces today that it has signed an agreement to acquire EUCODIS Bioscience.

MOBILion System Inc. has announced that it has appointed Jenn Buechel to serve on its board of directors, effective immediately.

Voltron Therapeutics, Inc. has announced that data from the previously announced Study ‘098 demonstrated clear Proof-of Concept for VTX-067 in the treatment of HPV-related cancers.

Biotium has announced the release of new ExoBrite Antibody Conjugates. These antibodies were curated specifically for optimal detection of exosome markers CD9, CD63 and CD81 in isolated exosomes or exosome extracts with little to no background.

A screening tool developed in research led at the University of Strathclyde, UK could increase the number of tests on a solid tumor sample by up to 50 times.

At this year’s Achema in Frankfurt, Syntegon will present new solutions for the filling of liquid pharmaceuticals, promoting the Versynta FFP (Flexible Filling Platform).

MaxCyte, Inc. has announced the signing of a strategic platform license with LG Chem Ltd.

Bio-Rad Laboratories, Inc. today extended its range of recombinant monoclonal anti-idiotypic antibodies with the introduction of antibodies specific to brentuximab vedotin, secukinumab and the secukinumab–interleukin 17A drug-target complex.

Centauri Therapeutics Limited has announced three senior appointments: Dr. Jennifer Schneider as CEO, Dr. Helen Bright as vice president of research & development and Professor David Roblin FRCP FMedSci as chair of the board of directors.